Global Stem Cell Manufacturing Market Insights, Size and Growth Forecast To 2030

COVID-19
Stem Cell Manufacturing Market Size, Share & Trends Analysis By Product, By Application, By End-User, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
Request COVID-19
impact analysis

Stem Cell Manufacturing Market Size, Share & Trends Analysis By Product, By Application, By End-User, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030

Published: Apr 2022 Base Year: 2021 Report ID: BIOT2220
Available Format: Historical Data: 2019 - 2020 Number of Pages: 1 - 236
Category : Biotechnology


Global Stem Cell Manufacturing Market projected to be worth USD 24.77 billion by 2030.

According to SPER Market Research, the Stem Cell Manufacturing Market estimated to reach USD 24.77 billion by 2030 with a CAGR of 8.9%. Encouraging regulatory framework, increasing investments in stem cell-based research, and growing alertness regarding the therapeutic potency of stem cell products; are the fuels for the escalation of the market.

Impact of COVID-19 on the Stem Cell Manufacturing Market 
The outbreak of COVID-19; lead to lockdown globally, in turn negatively impacted the stem cell manufacturing market.

Scope of the report:
 Report Metric Details
 Market size available for years 2019-2030
 Base year considered 2021
 Forecast period 2022-2030
 Segments coveredBy Product, By Application, By End-User, By Region
 Geographies covered North America, Europe, Asia Pacific, Latin America , Middle East, Africa
 Companies CoveredAnterogen, Becton, Bio-Rad Laboratories, Bio-Techne Corporation, Cellgenix GMBH, Corning Inc., Danaher Corporation, Dickinson and Company, Eppendorf AG, Fujifilm Holdings Corporation, Getinge, Himedia Laboratories, Lonza Group AG, Merck Millipore, Miltenyi Biotec, Promocell, Sartorius AG, Stemcell Technologies, Takara Bio Group, Terumo BCT Inc., Thermo Fisher Scientific. 

Driver: increasing venture capital investments in stem cell research
The increase in the public-private partnership investment in research for developing stem cell based technology. Stem cells are effective in disease management, personalized medicine and genomic testing.

Restraint: operational costs allied with stem cell manufacturing and banking
Expert techniques are used for stem cell isolation, purification, and storage. High operational cost coupled with stem cell manufacturing. Therefore, stem cell products are frequently available at a higher price than pharmaceutical drugs and biologics.

Opportunity: encouraging regulatory framework across developing countries
Regulatory reforms in the stem cell industries by the emerging countries meant for commercialization and research allied to stem cell therapy. Encouraging regulatory frameworks across developing countries are anticipated to offer huge opportunities to players in the market.

Challenges:
Technical limitations coupled with manufacturing scale-up, Socio-ethical concerns associated to the use of allogeneic and human embryonic stem cells; are the challenges to the market.



Global Stem Cell Manufacturing Market, By Product:
Based on the Product, Global Stem Cell Manufacturing Market is segmented as; Consumables (Culture Media, Other Consumables), Instruments (Bioreactors and Incubators, Cell Sorters, Other Instruments), Stem Cell Lines [Embryonic stem cells (ESC), Hematopoietic stem cells (HSC), Induced Pluripotent Stem cells (iPSC), Mesenchymal stem cells (MSC), Multipotent adult progenitor stem cells, Neural Stem cells (NSC)].

Global Stem Cell Manufacturing Market, By Application:
Based on the Application, Global Stem Cell Manufacturing Market is segmented as; Research Applications (Life science research, Drug discovery and development), Clinical Application (Allogenic stem cell therapy, Autologous stem cell therapy), Cell & Tissue Banking Applications.

Global Stem Cell Manufacturing Market, By End-User:
Based on the End-User, Global Stem Cell Manufacturing Market is segmented as; Pharmaceutical & Biotechnology Companies, Academic institutes, Research laboratories & contract research organizations, Hospitals & surgical centers, Cell & tissue banks, Other End Users.

Global Stem Cell Manufacturing Market, By Region:
North America dominates the prime share of the stem cell manufacturing market; and this is due to the public-private funding and grants, extensive in progress stem cell research activities and support for the clinical evaluation of stem cells.

1. Introduction
1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology
2.1 Research data source
2.1.1 Secondary data
2.1.2 Primary data
2.1.3 SPER’s internal database
2.1.4 Premium insight from KOL’s
2.2 Market size estimation
2.2.1 Top-down and Bottom-up approach
2.3 Data triangulation

3. Executive Summary

4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges 
4.2. COVID-19 Impacts of the Stem Cell Manufacturing Market 

5. Market variables and outlook
5.1. SWOT analysis 
5.1.1 Strengths 
5.1.2 Weaknesses 
5.1.3 Opportunities
5.1.4 Threats
5.2. PESTEL analysis 
5.2.1 Political landscape
5.2.2 Economic landscape
5.2.3 Social landscape 
5.2.4 Technological landscape 
5.2.5 Environmental landscape 
5.2.6 Legal landscape 
5.3. PORTER’S five forces analysis 
5.3.1 Bargaining power of suppliers 
5.3.2 Bargaining power of Buyers 
5.3.3 Threat of Substitute 
5.3.4 Threat of new entrant 
5.3.5 Competitive rivalry
5.4. Heat map analysis

6. Global Stem Cell Manufacturing Market, By Product, 2019-2030 (USD Million)
6.1.  Consumables
6.1.1. Culture Media
6.1.2. Other Consumables
6.2.  Instruments
6.2.1. Bioreactors and Incubators
6.2.2. Cell Sorters
6.2.3. Other Instruments
6.3.  Stem Cell Lines
6.3.1 Embryonic stem cells (ESC)
6.3.2 Hematopoietic stem cells (HSC)
6.3.3 Induced Pluripotent Stem cells (iPSC)
6.3.4 Mesenchymal stem cells (MSC)
6.3.5 Multipotent adult progenitor stem cells
6.3.6 Neural Stem cells (NSC)

7. Global Stem Cell Manufacturing Market, By Application, 2019-2030 (USD Million)
7.1. Research Applications
7.1.1.  Life science research
7.1.2.  Drug discovery and development
7.2. Clinical Application
7.2.1.  Allogenic stem cell therapy
7.2.2.  Autologous stem cell therapy
7.3. Cell & Tissue Banking Applications

8. Global Stem Cell Manufacturing Market, By  End-User, 2019-2030 (USD Million)
8.1. Academic institutes, Research laboratories & contract research organizations
8.2. Cell & tissue banks
8.3. Hospitals & surgical centres
8.4. Other End Users
8.5. Pharmaceutical & Biotechnology Companies

9. Global Stem Cell Manufacturing Market, By Region, 2019-2030 (USD Million)
9.1. North America
9.1.1. United States
9.1.2. Canada
9.1.3. Mexico
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. Australia
9.3.5. South Korea
9.3.6. Rest of Asia-Pacific
9.4. South America
9.4.1. Brazil
9.4.2. Argentina
9.4.3. Rest of South America
9.5. Middle East & Africa
9.5.1. Kingdom of Saudi Arabia 
9.5.2. United Arab Emirates
9.5.3. Rest of Middle East & Africa

10. Company Profiles
10.1. Anterogen 
10.1.1. Company details 
10.1.2. Financial outlook
10.1.3. Product summary 
10.1.4. Recent developments
10.2. Becton
10.2.1. Company details 
10.2.2. Financial outlook
10.2.3. Product summary 
10.2.4. Recent developments
10.3. Bio-Rad Laboratories 
10.3.1. Company details 
10.3.2. Financial outlook
10.3.3. Product summary 
10.3.4. Recent developments
10.4. Bio-Techne Corporation
10.4.1. Company details 
10.4.2. Financial outlook
10.4.3. Product summary 
10.4.4. Recent developments
10.5. Cellgenix GMBH 
10.5.1. Company details 
10.5.2. Financial outlook
10.5.3. Product summary 
10.5.4. Recent developments
10.6. Corning Inc. 
10.6.1. Company details 
10.6.2. Financial outlook
10.6.3. Product summary 
10.6.4. Recent developments
10.7. Danaher Corporation 
10.7.1. Company details 
10.7.2. Financial outlook
10.7.3. Product summary 
10.7.4. Recent developments
10.8. Dickinson and Company 
10.8.1. Company details 
10.8.2. Financial outlook
10.8.3. Product summary 
10.8.4. Recent developments
10.9. Eppendorf AG 
10.9.1. Company details 
10.9.2. Financial outlook
10.9.3. Product summary 
10.9.4. Recent developments
10.10. Fujifilm Holdings Corporation 
10.10.1. Company details 
10.10.2. Financial outlook
10.10.3. Product summary 
10.10.4. Recent developments
10.11. Getinge 
10.11.1. Company details 
10.11.2. Financial outlook
10.11.3. Product summary 
10.11.4. Recent developments
10.12. Himedia Laboratories 
10.12.1. Company details 
10.12.2. Financial outlook
10.12.3. Product summary 
10.12.4. Recent developments
10.13. Lonza Group AG 
10.13.1. Company details 
10.13.2. Financial outlook
10.13.3. Product summary 
10.13.4. Recent developments
10.14. Merck Millipore
10.14.1. Company details 
10.14.2. Financial outlook
10.14.3. Product summary 
10.14.4. Recent developments
10.15. Miltenyi Biotec 
10.15.1. Company details 
10.15.2. Financial outlook
10.15.3. Product summary 
10.15.4. Recent developments
10.16. Promocell 
10.16.1. Company details 
10.16.2. Financial outlook
10.16.3. Product summary 
10.16.4. Recent developments
10.17. Sartorius AG 
10.17.1. Company details 
10.17.2. Financial outlook
10.17.3. Product summary 
10.17.4. Recent developments
10.18. Stemcell Technologies 
10.18.1. Company details 
10.18.2. Financial outlook
10.18.3. Product summary 
10.18.4. Recent developments
10.19. Takara Bio Group 
10.19.1. Company details 
10.19.2. Financial outlook
10.19.3. Product summary 
10.19.4. Recent developments
10.20. Terumo BCT Inc. 
10.20.1. Company details 
10.20.2. Financial outlook
10.20.3. Product summary 
10.20.4. Recent developments
10.21. Thermo Fisher Scientific 
10.21.1. Company details 
10.21.2. Financial outlook
10.21.3. Product summary 
10.21.4. Recent developments

SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Global Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings.  The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

SPER-Methodology-1

SPER-Methodology-2

SPER-Methodology-3

Not able to find what you are looking for? Need customization in the existing report?
Click Here
PLACE AN ORDER
  • 15% off
     
    $ 4250
  • 20% off
             
    $ 5650
  • 25% off
         
    $ 7450
Pre-Purchase Inquiry
SEND AN INQUIRY
NEED CUSTOMIZATION?
Request Customization
100% Secure Payment

SPER American Express
SPER VISA
SPER Master Card
SPER Mestro
SPER Paypal
SPER CCAvenues

Join SPER Panel

Our Global Clients

Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Microsoft
SPER-EY
SPER-Sanofi
SPER-p&g
SPER-Johnson & Johnson
SPER-SIEMENS
SPER-LOREAL
SPER-Pfizer
SPER-IPSOS
SPER-Heineken
SPER-IQVIA
SPER-Kankar IMRB
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Microsoft
SPER-EY
SPER-Sanofi
SPER-p&g
SPER-Johnson & Johnson
SPER-SIEMENS
SPER-LOREAL
SPER-Pfizer
SPER-IPSOS
SPER-Heineken
SPER-IQVIA
SPER-Kankar IMRB

SPER

Market Research

We are the leading, full-service global market research and consulting company.

Certificates
iso-1 iso-1
Secure Payments
SPER Payment Options
Connect with us